Teos Therapeutics downgraded to Hold after belrestotug failure and GSK deal ending. Read my updated analysis on ITOS stock ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

A £1.5million project to make a stretch of the A7 more pedestrian friendly will start work in July after it was given the ...

A stretch of 37th Street in Evans will be closed for more than three months as the city kicks off three major infrastructure ...

CHARLOTTE ( CAROLINA SPORTS LIVE) — UNC Charlotte has released new renderings for the first expansion phase of Jerry ...

With summer commitment season rapidly approaching, and a good chunk of the offseason camp circuit already in the books, it's ...

The new acquisition from Boston Pharmaceuticals adds to a wave of dealmaking undertaken by GSK to build its liver disease ...

Zynlonta manufacturer ADC Therapeutics is continuing to prune its pipeline, calling time on its sole clinical-stage candidate ...

Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...

Allogene Therapeutics is cutting back to stretch its cash runway into the second half of 2027, laying off 28% of its ...

Gstar has completed the first phase of its factory in the Philippines, set to produce 1 GW of solar modules and 1.5 GW of solar cells. The Singapore-based solar manufacturer says a planned second ...

It was also demanded that Bondi reveal whether she was instructed to redact Trump's name or likeness from the Epstein Files.